# Telcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/telcare

- Industry: Medical Devices & Equipment
- Headquarters: Concord, US
- Website: www.telcare.com
- Total disclosed funding: $60M
- Latest round: Series C (Oct 20, 2014)
- Investors on record: 4

## About

Telcare, Inc. is a healthcare technology company that specializes in remote patient monitoring solutions, aiming to improve chronic disease management through innovative health data analytics and monitoring systems.Telcare, Inc., founded in 2008 in Concord, US, focuses on developing remote patient monitoring solutions. In December 2016, CardioNet Inc. acquired Telcare for USD 7 mn, integrating its assets into CardioNet’s operations. This acquisition marked a significant pivot in Telcare's strategy to enhance its market presence in healthcare technology.Telcare, Inc. offers remote patient monitoring and diagnostics solutions aimed at improving healthcare delivery for chronic conditions. The company’s core products include advanced monitoring systems that enable real-time health data collection and analysis for tracking vital signs and managing chronic diseases. Key product functionalities include automated monitoring for irregular heartbeats, resupply algorithms, and alarms for out-of-range measurements. These solutions serve healthcare providers, hospitals, and patients, especially in rural areas, across North America, Europe, and Asia.Telcare, Inc. generates revenue through subscription-based models and partnerships with healthcare organizations, integrating its technology into care workflows. The company's flagship products are crucial to its service offerings, accommodating various healthcare delivery scales.The most recent deal, finalized on December 1, 2016, involved CardioNet Inc. acquiring Telcare Medical Supply, Inc. for USD 7 mn, which is expected to facilitate the development of new products and expand into new markets. The integration of resources will support Telcare in launching innovative monitoring solutions within the next year, targeting healthcare institutions in North America and Europe for broader reach.

## Funding rounds

- Series C, Oct 20, 2014, $35M — Hong Shan, Norwest Venture Partners, Qualcomm Ventures, Mosaic Health Solutions
- Series B, Aug 21, 2012, $25M — Hong Shan, Qualcomm Ventures

## Investors

- Hong Shan — Series B, Series C
- Qualcomm Ventures (https://capitalatlas.ai/funds/qualcomm-ventures) — Series B, Series C
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series C
- Mosaic Health Solutions (https://capitalatlas.ai/funds/mosaic-health-solutions) — Series C